BiotechTubeBiotechTube
Home/Telomir Pharmaceuticals/Alan Weichselbaum
AW

Alan Weichselbaum

Chief Financial Officer

Telomir Pharmaceuticals

Therapeutic Areas

Longevity/AgingMetabolic DisordersNeurodegenerative DiseasesOphthalmologyRare DiseasesOncology

Telomir Pharmaceuticals Pipeline

DrugIndicationPhase
Telomir-1Age Reversal / LongevityPre-clinical

Leadership Team at Telomir Pharmaceuticals

EA
Erez Aminov
Chairman and Chief Executive Officer
IA
Itzchak Angel
Chief Scientific Advisor
AW
Alex Weisman
Scientific Advisor
FE
Francis E. O’Donnell, Jr.
Senior Advisor
PM
Peter McDonnell
Special Advisor
MR
Michael Roizen
Special Advisor
NM
Ned MacPherson
Director
MP
Matthew Pratt Whalen
Director
MP
Matthew P. Del Giudice
Director
View full Telomir Pharmaceuticals profile